{"DataElement":{"publicId":"2841307","version":"1","preferredName":"Cancer Quality of Care Measure Name Code","preferredDefinition":"The symbols used to represent the words by which an instrument that determines the magnitude of the degree of excellence with respect to medical services received for the treatment of a tumor is known.","longName":"CA_QOC_MEAS_NM_CD","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2841296","version":"1","preferredName":"Cancer Quality of Care Measure Name","preferredDefinition":"The words by which an instrument that determines the magnitude of the degree of excellence with respect to medical services received for the treatment of a tumor is known.","longName":"CA_QOC_MEAS_NM","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2841182","version":"1","preferredName":"Malignant Neoplasm Quality of Care Measurement","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004:The degree or grade of excellence with respect to medical services received by patients, administered by providers or programs, in terms of technical competence, need, appropriateness, acceptability, humanity and structure.:Measurement; the size or magnitude of something.","longName":"C9305:C17046:C25209","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Quality of Care","conceptCode":"C17046","definition":"The degree or grade of excellence with respect to medical services received by patients, administered by providers or programs, in terms of technical competence, need, appropriateness, acceptability, humanity and structure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Measurement","conceptCode":"C25209","definition":"Annotation used to indicate the size or magnitude of something that was determined by comparison to a standard.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"63B24B14-206C-56C6-E040-BB89AD430A7E","latestVersionIndicator":"Yes","beginDate":"2009-02-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2009-02-24","modifiedBy":"ONEDATA","dateModified":"2009-02-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2222841","version":"1","preferredName":"Name","preferredDefinition":"The words or language units by which a thing is known.","longName":"C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F6211245-8062-4DD9-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-02","endDate":null,"createdBy":"UMLLOADER_EVS","dateCreated":"2005-05-02","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"63C5AD0F-F588-91F3-E040-BB89AD432FEF","latestVersionIndicator":"Yes","beginDate":"2009-02-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2009-02-25","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2841298","version":"1","preferredName":"Cancer Quality of Care Measure Name Code","preferredDefinition":"The symbols used to represent the words by which an instrument that determines the magnitude of the degree of excellence with respect to medical services received for the treatment of a tumor is known.","longName":"CA_QOC_MEAS_NM_CD","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"ALPHANUMERIC","minLength":null,"maxLength":"8","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"RecRt","valueDescription":"Radiation Therapy For Rectal Carcinoma","ValueMeaning":{"publicId":"2841299","version":"1","preferredName":"Radiation Therapy For Rectal Carcinoma","longName":"2841299v1.00","preferredDefinition":"Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation._The reason of something._A malignant epithelial neoplasm that arises from the rectum. The vast majority are adenocarcinomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Radiation Therapy","conceptCode":"C15313","definition":"Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"For","conceptCode":"C64956","definition":"The reason of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Rectal Carcinoma","conceptCode":"C9382","definition":"A malignant epithelial neoplasm that arises from the rectum. The vast majority are adenocarcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"63C5AD0F-F5D3-91F3-E040-BB89AD432FEF","latestVersionIndicator":"Yes","beginDate":"2009-02-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2009-02-25","modifiedBy":"KUMMEROA","dateModified":"2023-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"63C5AD0F-F5EC-91F3-E040-BB89AD432FEF","beginDate":"2009-02-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2009-02-25","modifiedBy":"ONEDATA","dateModified":"2009-02-25","deletedIndicator":"No"},{"value":"ACT","valueDescription":"Adjuvant Chemotherapy For Stage III Colon Carcinoma","ValueMeaning":{"publicId":"2841300","version":"1","preferredName":"Adjuvant Chemotherapy For Stage III Colon Carcinoma","longName":"2841300v1.00","preferredDefinition":"An agent that enhances the activity or therapeutic effect of another pharmacologic substance without having much, if any, therapeutic impact by itself._The use of synthetic or naturally-occurring chemicals for the treatment of diseases._The reason of something._Locally advanced cancer that has spread to nearby organs but not to distant anatomic sites._A malignant epithelial neoplasm that arises from the colon and invades through the muscularis mucosa into the submucosa.  The vast majority are adenocarcinomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adjuvant","conceptCode":"C2140","definition":"An agent that enhances the activity or therapeutic effect of another pharmacologic substance without having much, if any, therapeutic impact by itself.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Chemotherapy","conceptCode":"C15632","definition":"The use of synthetic or naturally-occurring chemicals for the treatment of diseases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"For","conceptCode":"C64956","definition":"The reason of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Stage III","conceptCode":"C27970","definition":"Locally advanced cancer that has spread to nearby organs but not to distant anatomic sites.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Colon Carcinoma","conceptCode":"C4910","definition":"A malignant epithelial neoplasm that arises from the colon and invades through the muscularis mucosa into the submucosa.  The vast majority are adenocarcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"63C5AD0F-F5FC-91F3-E040-BB89AD432FEF","latestVersionIndicator":"Yes","beginDate":"2009-02-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2009-02-25","modifiedBy":"KUMMEROA","dateModified":"2023-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"63C5AD0F-F615-91F3-E040-BB89AD432FEF","beginDate":"2009-02-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2009-02-25","modifiedBy":"ONEDATA","dateModified":"2009-02-25","deletedIndicator":"No"},{"value":"12RLN","valueDescription":"Integer::12 Regional Lymph Node For Colon Excision","ValueMeaning":{"publicId":"2841301","version":"1","preferredName":"Integer::12 Regional Lymph Node For Colon Excision","longName":"2841301v1.00","preferredDefinition":"A number with no fractional part, including the negative and positive numbers as well as zero.::12_A lymph node that drains lymph from a region of interest._The reason of something._The part of the large intestine measured from the cecum to the rectum consisting of ascending, transverse, descending and sigmoid portions. The purpose of the colon is to remove water from digested food prior to excretion._The surgical removal of a lesion, often as part of a biopsy and with healthy margins.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Regional Lymph Node","conceptCode":"C49018","definition":"A lymph node that drains lymph from a region of interest.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"For","conceptCode":"C64956","definition":"The reason of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Colon","conceptCode":"C12382","definition":"The part of the large intestine measured from the cecum to the rectum consisting of ascending, transverse, descending and sigmoid portions. The purpose of the colon is to remove water from digested food prior to excretion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Excision","conceptCode":"C15232","definition":"The surgical removal of a lesion, often as part of a biopsy and with healthy margins.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"63C5AD0F-F624-91F3-E040-BB89AD432FEF","latestVersionIndicator":"Yes","beginDate":"2009-02-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2009-02-25","modifiedBy":"KUMMEROA","dateModified":"2023-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"63C5AD0F-F63D-91F3-E040-BB89AD432FEF","beginDate":"2009-02-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2009-02-25","modifiedBy":"ONEDATA","dateModified":"2009-02-25","deletedIndicator":"No"},{"value":"HT","valueDescription":"Hormone Therapeutic Procedure For Breast Carcinoma","ValueMeaning":{"publicId":"2841302","version":"1","preferredName":"Hormone Therapeutic Procedure For Breast Carcinoma","longName":"2841302v1.00","preferredDefinition":"Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process._The reason of something._A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hormone","conceptCode":"C2315","definition":"Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"For","conceptCode":"C64956","definition":"The reason of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Breast Carcinoma","conceptCode":"C4872","definition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"63C5AD0F-F64C-91F3-E040-BB89AD432FEF","latestVersionIndicator":"Yes","beginDate":"2009-02-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2009-02-25","modifiedBy":"KUMMEROA","dateModified":"2023-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"63C5AD0F-F665-91F3-E040-BB89AD432FEF","beginDate":"2009-02-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2009-02-25","modifiedBy":"ONEDATA","dateModified":"2009-02-25","deletedIndicator":"No"},{"value":"MAC","valueDescription":"Multiple Agent Chemotherapy For Breast Carcinoma","ValueMeaning":{"publicId":"2841303","version":"1","preferredName":"Multiple Agent Chemotherapy For Breast Carcinoma","longName":"2841303v1.00","preferredDefinition":"Having, relating to, or consisting of more than one individual, element, part, or other component; manifold._An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect._The use of synthetic or naturally-occurring chemicals for the treatment of diseases._The reason of something._A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Multiple","conceptCode":"C17648","definition":"Having, relating to, or consisting of more than one individual, element, part, or other component; manifold.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Agent","conceptCode":"C1708","definition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Chemotherapy","conceptCode":"C15632","definition":"The use of synthetic or naturally-occurring chemicals for the treatment of diseases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"For","conceptCode":"C64956","definition":"The reason of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Breast Carcinoma","conceptCode":"C4872","definition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"63C5AD0F-F675-91F3-E040-BB89AD432FEF","latestVersionIndicator":"Yes","beginDate":"2009-02-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2009-02-25","modifiedBy":"KUMMEROA","dateModified":"2023-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"63C5AD0F-F68E-91F3-E040-BB89AD432FEF","beginDate":"2009-02-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2009-02-25","modifiedBy":"ONEDATA","dateModified":"2009-02-25","deletedIndicator":"No"},{"value":"BCS","valueDescription":"Breast Conservation Surgical Procedure And Radiation Therapy","ValueMeaning":{"publicId":"2841305","version":"1","preferredName":"Breast Conservation Surgical Procedure And Radiation Therapy","longName":"2841305","preferredDefinition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.: The maintenance of certain characteristics in an unchanged condition.: Used for operative procedures on organs, regions, or tissues in the treatment of diseases, including tissue section by lasers. It excludes transplantation, for which \"transplantation\" is used.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: use PHOTOTHERAPY, LASER THERAPY, or ULTRAVIOLET THERAPY for therapeutic radiation with visible, laser, or ultraviolet light, respectively.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast","conceptCode":"C12971","definition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Conservation","conceptCode":"C71463","definition":"The maintenance of certain characteristics in an unchanged condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Surgical Procedure","conceptCode":"C15329","definition":"A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Radiation Therapy","conceptCode":"C15313","definition":"Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"63C5AD0F-F69F-91F3-E040-BB89AD432FEF","latestVersionIndicator":"Yes","beginDate":"2009-02-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2009-02-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"63C5AD0F-F6B8-91F3-E040-BB89AD432FEF","beginDate":"2009-02-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2009-02-25","modifiedBy":"ONEDATA","dateModified":"2009-02-25","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2841297","version":"1","preferredName":"Malignant Neoplasm Quality of Care Measurement Name Code","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004:The degree or grade of excellence with respect to medical services received by patients, administered by providers or programs, in terms of technical competence, need, appropriateness, acceptability, humanity and structure.:Measurement; the size or magnitude of something.:The words or language units by which a thing is known.:A system of numbered categories for representation of data.","longName":"2841297v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Quality of Care","conceptCode":"C17046","definition":"The degree or grade of excellence with respect to medical services received by patients, administered by providers or programs, in terms of technical competence, need, appropriateness, acceptability, humanity and structure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Measurement","conceptCode":"C25209","definition":"Annotation used to indicate the size or magnitude of something that was determined by comparison to a standard.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"63C5AD0F-F5AB-91F3-E040-BB89AD432FEF","latestVersionIndicator":"Yes","beginDate":"2009-02-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2009-02-25","modifiedBy":"HEBELL","dateModified":"2009-03-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"63C5AD0F-F5BC-91F3-E040-BB89AD432FEF","latestVersionIndicator":"Yes","beginDate":"2009-02-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2009-02-25","modifiedBy":"KUMMEROA","dateModified":"2023-08-22","changeDescription":null,"administrativeNotes":"2023.8.22 Updated PV defs for 'No Value Exists'. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"CAN_QC_MSR_NM_CD","type":"C3D Name","context":"NCIP"}],"ReferenceDocuments":[{"name":"RQRS Measure Name","type":"Preferred Question Text","description":"RQRS Measure Name","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"63C5AD0F-F6CE-91F3-E040-BB89AD432FEF","latestVersionIndicator":"Yes","beginDate":"2009-02-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2009-02-25","modifiedBy":"CURTIST","dateModified":"2011-03-03","changeDescription":"3/3/2011 - tc - removed NAACCR 11.1 classification as it was in error.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}